Exam Details
| Subject | pharmacology and toxicology (262911) | |
| Paper | ||
| Exam / Course | m.pharm. | |
| Department | ||
| Organization | Dr.M.G.R. Medical University | |
| Position | ||
| Exam Date | May, 2019 | |
| City, State | tamil nadu, chennai |
Question Paper
THE TAMIL NADU DR. M.G.R. MEDICAL UNIVERSITY
[LO 350] MAY 2019 Sub. Code: 2911
M.PHARM. DEGREE EXAMINATION
FIRST YEAR
BRANCH IV PHARMACOLOGY
PAPER II PHARMACOLOGY AND TOXICOLOGY
Q.P. Code: 262911
Time: Three hours Maximum 100 Marks
I. Elaborate on: x 20 40)
1. The steps involved in neurohumoral transmission in ANS and drugs affecting
them.
2. The various mechanisms of drug absorption and factors affecting abruption of
drugs.
II. Write notes on: (10 x 6 60)
1. Hepatic clearance of drugs.
2. Mechanism, pharmacological actions and adverse effects of thiazide diuretics.
3. Combination of levodopa and carbidopa.
4. Heavy metal poisoning and their antagonists.
5. Role of antioxidants in treatment of diseases.
6. Depolarizing and non-depolarizing neuromuscular blocking agents-a comparison.
7. Fluroquinolones.
8. Drugs used in treatment of anxiety.
9. Role of beta blockers in treatment of diseases.
10. Nucleoside reverse transcriptase inhibitors.
[LO 350] MAY 2019 Sub. Code: 2911
M.PHARM. DEGREE EXAMINATION
FIRST YEAR
BRANCH IV PHARMACOLOGY
PAPER II PHARMACOLOGY AND TOXICOLOGY
Q.P. Code: 262911
Time: Three hours Maximum 100 Marks
I. Elaborate on: x 20 40)
1. The steps involved in neurohumoral transmission in ANS and drugs affecting
them.
2. The various mechanisms of drug absorption and factors affecting abruption of
drugs.
II. Write notes on: (10 x 6 60)
1. Hepatic clearance of drugs.
2. Mechanism, pharmacological actions and adverse effects of thiazide diuretics.
3. Combination of levodopa and carbidopa.
4. Heavy metal poisoning and their antagonists.
5. Role of antioxidants in treatment of diseases.
6. Depolarizing and non-depolarizing neuromuscular blocking agents-a comparison.
7. Fluroquinolones.
8. Drugs used in treatment of anxiety.
9. Role of beta blockers in treatment of diseases.
10. Nucleoside reverse transcriptase inhibitors.
Other Question Papers
Subjects
- advanced medicinal chemistry (262906)
- advanced organic chemistry (262905)
- advanced pharmacognosy (262923)(no candidate)
- advances in drug delivery system (262904)
- advances in pharmaceutical bio-technology (262919)
- bio-pharmaceutics and pharmacokinetics (262903)
- bio-process technology (262918) (no candidate)
- biogenesis and chemistry of natural products(262909)
- biological standardisation and pharmacological screening methods (262912)
- biological standardisation and pharmacological screening methods (262915)
- clinical pharmacy (262922)
- drug design and molecular pharmacology (262913)
- drug design and molecular pharmacology (262916)
- herbal drug development and standardisation(262924)
- hospital and community pharmacy (262921)
- indian systems of medicine (262925)
- industrial pharmacy (262902)
- modern pharmaceutical analytical techniques (262901)
- natural products of medicinal interest (262907)
- pharmaceutical aspects of microbial and cellular biology (262917) (no candidate)
- pharmacognosy(262908)
- pharmacology and toxicology (262911)
- pharmacology and toxicology (262914)
- pharmacotherapeutics (including pathophysiology) (262920)
- phytochemistry and biotechnology(262910)(no candidate)